Crossmark

Design and development of dual targeting CAR protein for the development of CAR T-cell therapy against KRAS mutated pancreatic ductal adenocarcinoma using computational approaches

Crossref DOI link: https://doi.org/10.1007/s12672-024-01455-6

Published Online: 2024-10-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ramalingam, Prasanna Srinivasan https://orcid.org/0000-0002-8281-2779
Premkumar, T. https://orcid.org/0009-0006-0651-8259
Sundararajan, Vino https://orcid.org/0000-0002-0015-8460
Hussain, Md Sadique https://orcid.org/0000-0002-3554-1750
Arumugam, Sivakumar https://orcid.org/0000-0001-8834-8834
Funding

Funding for this research was provided by:

Vellore Institute of Technology, Vellore
License Information

Text and Data Mining valid from 2024-10-25

Version of Record valid from 2024-10-25
More Information

Article History

Received: 24 July 2024

Accepted: 11 October 2024

First Online: 25 October 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below